Orbimed Advisors LLC Adicet Bio, Inc. Transaction History
Orbimed Advisors LLC
- $4.15 Billion
- Q2 2024
A detailed history of Orbimed Advisors LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 11,447,140 shares of ACET stock, worth $16.4 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
11,447,140
Previous 11,447,140
-0.0%
Holding current value
$16.4 Million
Previous $26.9 Million
48.51%
% of portfolio
0.33%
Previous 0.61%
Shares
6 transactions
Others Institutions Holding ACET
# of Institutions
96Shares Held
66.3MCall Options Held
4.3KPut Options Held
36.3K-
Tang Capital Management LLC San Diego, CA8.22MShares$11.8 Million1.21% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$10.8 Million0.14% of portfolio
-
Goldman Sachs Group Inc New York, NY4.28MShares$6.13 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.62MShares$5.18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.1MShares$4.43 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $57.2M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...